Magnetic nanoparticles achieve 98% sensitivity for amoxicillin allergy detection

A multidisciplinary research team at the University of Malaga has unveiled a new diagnostic technology that uses magnetic nanoparticles to identify allergic reactions to beta‑lactam antibiotics, including amoxicillin and other penicillins. The method is designed to deliver precise, rapid, and reliable results, addressing the need for improved testing in a field where conventional skin tests and serum IgE assays can be time‑consuming and sometimes inconclusive.

The nanoparticle‑based platform operates by detecting specific immune responses to beta‑lactam compounds, allowing clinicians to confirm or rule out allergy within a short timeframe. Researchers say the approach combines expertise from immunology, nanotechnology, and clinical medicine, and preliminary trials have demonstrated high sensitivity and specificity. If further validated, the technology could streamline allergy assessment, reduce unnecessary avoidance of first‑line antibiotics, and support more targeted treatment decisions in healthcare settings.